About Aryastha
Aryastha is a Healthcare company based in Hyderabad (India) founded in 2023 by Raghava Reddy Kethri and Pradip K Majumder. Contract research services for drug discovery and development are provided. Aryastha has raised $2.13 million across 1 funding round from investors including Vessella. The company has 1 employees. Aryastha was last valued at $11.37 million in August 2023. Its chief executive, as recorded, is Raghava Reddy Kethri. Aryastha offers products and services including Discovery Chemistry, Discovery Biology, Pre-Clinical DMPK, and Development Services. Its focus areas include Biopharma Outsourcing and Diversified. Its legal entity in India is Aryastha Life Sciences Private Limited (U72100TS2023PTC175080).
Company details
Aryastha was founded in 2023 in Hyderabad, India, as a contract research and development entity in the pharmaceutical sector. Services encompass drug discovery, medicinal chemistry, pre-clinical development, toxicology assessments, formulation progression, analytical evaluations, and infrastructure support. Operations are centered on supporting pharmaceutical advancements through specialized expertise and facilities in the region.
- Headquarters Hyderabad, India
- Employees 1
- Founders Raghava Reddy Kethri, Pradip K Majumder
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website aryastha.com
- Social LinkedIn X Facebook Instagram
- Legal Name Aryastha Life Sciences Private Limited
- Date of Incorporation 18 Jul, 2023
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹84,462
FY 2024
- Net Loss-₹45.7 Lakh
FY 2024 · -5414% margin
- EBITDA-₹57.9 Lakh
FY 2024 · -6859% margin
- Total Equity Funding$2.13M (USD)
in 1 rounds
- Latest Funding Round$2.13M (USD), Series A
Aug 2023
- Investors
- Employee Count1
Associated legal entities of Aryastha
Aryastha operates through Aryastha Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Aryastha Life Sciences Private Limited CIN U72100TS2023PTC175080 | Active | 18 Jul 2023 | Hyderabad, Telangana | ₹0.0 Cr | 51 | 5 | View details |
Products & Services of Aryastha
Aryastha offers a comprehensive portfolio of products and services, including Discovery Chemistry, Discovery Biology, Pre-Clinical DMPK, and Development Services.
Involves developing new medicines through chemical processes.
Utilizes cell lines and models for drug testing and development.
Evaluates drug metabolism and toxicity in preclinical stages.
Supports scaling from research to production with quality controls.
Funding Insights of Aryastha
Aryastha has successfully raised a total of $2.13M through 1 strategic funding round. The most recent funding activity was a Series A round of $2.13 million completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.13M
- Total Rounds 1
- Last Round Series A — $2.13M
- First Round $2.13M
(Aug 2023)
- Investors Count 1
All 1 funding rounds of Aryastha with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2023 | $2.13M | Series A | $11.37M | Vessella | – |
| Date | Valuation | Stage |
|---|---|---|
| Aug 2023 | $11.37M | •••••••• |
Last known valuation $11.37M (Aug 2023). 1 investors in total: 1 institutional.
Investors in Aryastha
Aryastha has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Vessella.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Develops innovative technologies for real estate projects. | 2010 | vessella.com | Hyderabad, India |
Investor details for Aryastha
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Aryastha Life Sciences Private Limited (Aryastha)
Aryastha Life Sciences Private Limited is the primary company behind Aryastha. The board of Aryastha Life Sciences Private Limited currently have 5 directors; the longest-serving is Pradip Kumar Majumder, appointed in 2023. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Pradip Kumar Majumder DIN 02985222 | Director | 18 Jul 2023 | 3 yrs 3 mo | Aryastha Life Sciences Private Limited |
| Raghava Reddy Kethiri DIN 07819981 | Director | 18 Jul 2023 | 3 yrs 3 mo | Aryastha Life Sciences Private Limited |
| Rajasekar Narayanasamy DIN 02354436 | Additional Director | 31 Dec 2023 | 2 yrs 10 mo | Aryastha Life Sciences Private Limited |
| Sivananda Reddy Mandra DIN 02908235 | Additional Director | 31 Dec 2023 | 2 yrs 10 mo | Aryastha Life Sciences Private Limited |
| Mark Timothy Bilodeau DIN 11330898 | Director | 06 Oct 2025 | 1 yr | Aryastha Life Sciences Private Limited |
People of Aryastha
13 people are tracked at Aryastha (10 in leadership, 3 in team); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
Raghava Reddy Kethri | Co-Founder & CEO | Leadership |
| Co-Founder | Leadership | |
| Co-founder & CEO | Leadership | |
Avneesh Dubey | Director - Global Business Development | Leadership |
Laura Z. Sailor | Chief Business Officer | Leadership |
Krishna Reddy Gankidi | Associate Director | Leadership |
Biswanath Majumder | Associate Vice President | Leadership |
| Director | Leadership | |
Pradip K. Mujumdar | Director | Leadership |
Ansar Ali Khan | Director | Leadership |
Shivani Toorupu | Senior Executive I | Team |
Vishal Sartape | Senior Research Associate | Team |
Mohd Khalid Pasha | Group Leader | Team |
Complete people profiles for Aryastha
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Aryastha
Figures of Aryastha Life Sciences Private Limited, the primary company behind Aryastha, for FY 2024. Revenue was ₹84,462. Net loss was -₹45.7 Lakh (-5414% margin). EBITDA was -₹57.9 Lakh (-6859% margin).
- ₹84,462Revenue · FY 2024
- -₹45.7 LakhNet loss · -5414% margin
- -₹57.9 LakhEBITDA · -6859% margin
- ₹1.4 LakhPaid-up capital
- 51Employees (provident fund records)
Balance sheet, profit and loss, cash flow and ratios of Aryastha Life Sciences Private Limited are on its company page.
Detailed financial statements for Aryastha
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Aryastha
3 dated milestones of Aryastha, from founding to its latest funding, stage changes and deals.
- Founded Aryastha is founded.
- Funding First funding round of $2.1M.
- Milestone Reaches Minicorn status.
Web traffic of Aryastha
The website of Aryastha (aryastha.com) receives about 3.2K visits a month.
- Monthly visits3.2K
▼ 48.5% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Aryastha (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Aryastha
Complete news archive for Aryastha
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aryastha
Aryastha was founded in 2023.
Aryastha is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Raghava Reddy Kethri is the CEO of Aryastha, as recorded in our data. They have also founded this company.
Aryastha is a funded company, having raised a total of $2.13M across 1 funding round to date. The company's 1st funding round was a Series A of $2.13M, raised on Aug 2023.
Aryastha has 1 employees.
The primary company behind Aryastha, Aryastha Life Sciences Private Limited, reported revenue of ₹84,462 for FY 2024.
Aryastha was founded in 2023 in Hyderabad, India, as a contract research and development entity in the pharmaceutical sector. Services encompass drug discovery, medicinal chemistry, pre-clinical development, toxicology assessments, formulation progression, analytical evaluations, and infrastructure support. Operations are centered on supporting pharmaceutical advancements through specialized expertise and facilities in the region.
Aryastha offers Discovery Chemistry, Discovery Biology, Pre-Clinical DMPK, and Development Services.
Aryastha has 1 investor. Key investors include Vessella.
The valuation of Aryastha is $11.37M as of Aug 2023.
Aryastha operates through Aryastha Life Sciences Private Limited.
The legal entities of Aryastha currently have 5 directors, including Rajasekar Narayanasamy, Pradip Kumar Majumder, Sivananda Reddy Mandra and others.